Nifty
Sensex
:
:
22203.90
73041.08
81.85 (0.37%)
250.95 (0.34%)

Pharmaceuticals & Drugs - API

Rating :
43/99

BSE: 532488 | NSE: DIVISLAB

3577.35
26-Feb-2024
  • Open
  • High
  • Low
  • Previous Close
  •  3649.00
  •  3655.00
  •  3556.35
  •  3648.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  404285
  •  14527.64
  •  4074.40
  •  2730.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 94,984.66
  • 68.68
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 91,375.66
  • 0.84%
  • 7.29

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.92%
  • 1.36%
  • 8.85%
  • FII
  • DII
  • Others
  • 14.85%
  • 21.03%
  • 1.99%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.86
  • 9.45
  • 3.68

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.84
  • 4.81
  • -3.70

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.96
  • 6.15
  • -2.78

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 36.32
  • 49.15
  • 52.29

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.76
  • 8.97
  • 9.38

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 27.22
  • 31.72
  • 33.19

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
1,855.00
1,708.00
8.61%
1,909.00
1,855.00
2.91%
1,778.00
2,255.00
-21.15%
1,950.77
2,518.44
-22.54%
Expenses
1,366.00
1,299.00
5.16%
1,430.00
1,234.00
15.88%
1,274.00
1,407.00
-9.45%
1,463.18
1,414.02
3.48%
EBITDA
489.00
409.00
19.56%
479.00
621.00
-22.87%
504.00
848.00
-40.57%
487.59
1,104.42
-55.85%
EBIDTM
26.36%
23.95%
25.09%
33.48%
28.35%
37.61%
24.99%
43.85%
Other Income
95.00
113.00
-15.93%
86.00
80.00
7.50%
81.00
88.00
-7.95%
66.15
52.39
26.26%
Interest
0.00
0.00
0
1.00
0.00
0
0.00
0.00
0
0.24
0.08
200.00%
Depreciation
95.00
87.00
9.20%
95.00
86.00
10.47%
93.00
84.00
10.71%
87.02
80.99
7.45%
PBT
489.00
435.00
12.41%
469.00
615.00
-23.74%
492.00
852.00
-42.25%
466.48
1,075.74
-56.64%
Tax
131.00
129.00
1.55%
121.00
122.00
-0.82%
136.00
150.00
-9.33%
145.51
181.10
-19.65%
PAT
358.00
306.00
16.99%
348.00
493.00
-29.41%
356.00
702.00
-49.29%
320.97
894.64
-64.12%
PATM
19.30%
17.92%
18.23%
26.58%
20.02%
31.13%
16.45%
35.52%
EPS
13.51
11.55
16.97%
13.13
18.60
-29.41%
13.43
26.45
-49.22%
12.09
33.70
-64.12%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
7,492.77
7,767.51
8,959.83
6,969.40
5,394.42
4,946.26
3,891.49
4,064.34
3,776.36
3,114.94
2,532.14
Net Sales Growth
-10.12%
-13.31%
28.56%
29.20%
9.06%
27.10%
-4.25%
7.63%
21.23%
23.02%
 
Cost Of Goods Sold
3,054.58
3,053.72
2,967.14
2,324.08
2,108.54
1,825.22
1,534.06
1,534.00
1,505.32
1,213.24
914.15
Gross Profit
4,438.19
4,713.79
5,992.69
4,645.32
3,285.88
3,121.04
2,357.43
2,530.34
2,271.04
1,901.70
1,617.99
GP Margin
59.23%
60.69%
66.88%
66.65%
60.91%
63.10%
60.58%
62.26%
60.14%
61.05%
63.90%
Total Expenditure
5,533.18
5,398.40
5,078.72
4,108.34
3,571.21
3,073.24
2,628.74
2,617.20
2,358.04
1,948.69
1,516.76
Power & Fuel Cost
-
496.61
392.33
319.15
280.73
248.78
228.73
198.80
180.34
170.82
147.40
% Of Sales
-
6.39%
4.38%
4.58%
5.20%
5.03%
5.88%
4.89%
4.78%
5.48%
5.82%
Employee Cost
-
975.02
946.16
825.76
621.05
542.27
456.06
499.90
361.19
290.42
232.46
% Of Sales
-
12.55%
10.56%
11.85%
11.51%
10.96%
11.72%
12.30%
9.56%
9.32%
9.18%
Manufacturing Exp.
-
400.93
365.92
297.84
258.91
212.96
182.67
169.15
169.42
147.24
121.10
% Of Sales
-
5.16%
4.08%
4.27%
4.80%
4.31%
4.69%
4.16%
4.49%
4.73%
4.78%
General & Admin Exp.
-
302.99
236.44
175.26
148.62
105.30
139.33
88.22
73.91
63.85
51.74
% Of Sales
-
3.90%
2.64%
2.51%
2.76%
2.13%
3.58%
2.17%
1.96%
2.05%
2.04%
Selling & Distn. Exp.
-
113.82
127.01
124.03
85.36
73.08
64.02
67.48
56.04
51.93
44.22
% Of Sales
-
1.47%
1.42%
1.78%
1.58%
1.48%
1.65%
1.66%
1.48%
1.67%
1.75%
Miscellaneous Exp.
-
55.31
43.72
42.22
68.00
65.63
23.87
59.65
11.80
11.18
44.22
% Of Sales
-
0.71%
0.49%
0.61%
1.26%
1.33%
0.61%
1.47%
0.31%
0.36%
0.22%
EBITDA
1,959.59
2,369.11
3,881.11
2,861.06
1,823.21
1,873.02
1,262.75
1,447.14
1,418.32
1,166.25
1,015.38
EBITDA Margin
26.15%
30.50%
43.32%
41.05%
33.80%
37.87%
32.45%
35.61%
37.56%
37.44%
40.10%
Other Income
328.15
344.66
115.90
62.67
189.63
155.63
113.44
74.89
97.44
44.70
70.60
Interest
1.24
1.96
2.00
2.10
7.14
4.68
2.37
3.36
4.74
2.88
2.96
Depreciation
370.02
343.18
311.51
255.59
186.24
168.90
142.49
123.33
118.18
136.00
92.12
PBT
1,916.48
2,368.63
3,683.50
2,666.04
1,819.46
1,855.07
1,231.33
1,395.34
1,392.84
1,072.08
990.92
Tax
533.51
545.25
723.05
681.75
442.92
502.33
354.32
334.92
267.06
220.56
217.58
Tax Rate
27.84%
23.02%
19.63%
25.57%
24.34%
27.08%
28.78%
24.00%
19.17%
20.57%
21.96%
PAT
1,382.97
1,823.38
2,960.45
1,984.29
1,376.54
1,352.74
877.01
1,060.42
1,125.78
851.52
773.34
PAT before Minority Interest
1,382.97
1,823.38
2,960.45
1,984.29
1,376.54
1,352.74
877.01
1,060.42
1,125.78
851.52
773.34
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
18.46%
23.47%
33.04%
28.47%
25.52%
27.35%
22.54%
26.09%
29.81%
27.34%
30.54%
PAT Growth
-42.27%
-38.41%
49.19%
44.15%
1.76%
54.24%
-17.30%
-5.81%
32.21%
10.11%
 
EPS
52.09
68.68
111.50
74.74
51.85
50.95
33.03
39.94
42.40
32.07
29.13

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
12,767.09
11,728.18
9,294.61
7,309.92
6,957.15
5,924.80
5,357.39
4,293.31
3,495.36
2,963.35
Share Capital
53.09
53.09
53.09
53.09
53.09
53.09
53.09
53.09
26.55
26.55
Total Reserves
12,714.00
11,675.09
9,241.52
7,256.83
6,904.06
5,871.71
5,304.30
4,240.21
3,468.81
2,936.80
Non-Current Liabilities
556.36
436.51
363.94
294.57
991.38
1,768.91
1,411.75
85.17
841.57
650.05
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.47
1.05
1.55
Long Term Provisions
30.62
26.71
25.42
20.52
772.54
1,577.26
1,288.92
11.57
714.30
533.49
Current Liabilities
1,533.08
2,454.44
1,728.35
1,820.53
846.75
653.42
659.45
519.50
775.53
627.41
Trade Payables
762.51
795.70
763.20
590.72
492.26
411.21
445.80
232.69
226.87
151.70
Other Current Liabilities
331.44
394.02
340.42
290.09
243.59
175.46
176.63
240.58
203.45
147.80
Short Term Borrowings
0.00
0.00
0.35
33.63
105.60
63.11
35.74
41.42
25.07
16.32
Short Term Provisions
439.13
1,264.72
624.38
906.09
5.30
3.64
1.28
4.81
320.14
311.58
Total Liabilities
14,856.53
14,619.13
11,386.90
9,425.02
8,795.28
8,347.13
7,428.59
4,897.98
5,112.46
4,240.81
Net Block
4,722.60
4,325.05
3,703.87
2,781.85
2,087.77
1,996.19
1,559.19
1,438.77
1,308.89
1,221.84
Gross Block
6,364.76
5,624.27
4,691.86
3,514.25
2,633.93
2,373.45
1,793.95
2,196.08
1,953.02
1,740.34
Accumulated Depreciation
1,642.16
1,299.22
987.99
732.40
546.16
377.26
234.76
757.32
644.13
518.50
Non Current Assets
5,112.79
5,008.74
4,596.30
3,851.49
4,145.23
3,812.01
3,418.08
1,870.93
2,340.06
1,984.45
Capital Work in Progress
211.88
469.93
710.62
919.69
491.91
119.76
443.57
263.91
218.18
144.48
Non Current Investment
77.05
72.01
0.01
0.01
547.26
0.01
0.01
0.01
0.00
0.00
Long Term Loans & Adv.
97.61
133.70
172.59
144.50
1,012.93
1,688.23
1,406.48
162.44
812.63
618.03
Other Non Current Assets
3.65
8.05
9.21
5.44
5.36
7.82
8.83
5.80
0.35
0.09
Current Assets
9,743.74
9,610.39
6,790.60
5,573.53
4,650.05
4,535.12
4,010.51
3,027.04
2,772.40
2,256.35
Current Investments
0.00
0.00
0.00
971.35
1,398.34
1,889.28
1,630.72
802.85
733.00
501.88
Inventories
3,000.41
2,828.62
2,145.23
1,863.86
1,772.34
1,350.67
1,319.91
1,207.83
1,162.64
932.42
Sundry Debtors
1,792.53
2,423.88
1,676.52
1,413.35
1,163.37
1,014.36
900.92
880.92
741.64
723.70
Cash & Bank
4,213.09
2,818.88
2,156.03
122.63
115.26
112.46
78.70
73.43
65.22
40.51
Other Current Assets
737.71
29.69
51.95
52.16
200.74
168.35
80.26
62.01
69.89
57.85
Short Term Loans & Adv.
708.74
1,509.32
760.87
1,150.18
58.54
43.37
59.59
42.88
54.98
48.16
Net Current Assets
8,210.66
7,155.95
5,062.25
3,753.00
3,803.30
3,881.70
3,351.06
2,507.54
1,996.87
1,628.95
Total Assets
14,856.53
14,619.13
11,386.90
9,425.02
8,795.28
8,347.13
7,428.59
4,897.97
5,112.46
4,240.80

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
2,459.73
1,911.80
1,946.93
1,215.94
954.30
775.86
1,150.37
1,037.86
826.33
556.75
PBT
2,368.63
3,683.50
2,666.04
1,819.46
1,855.07
1,231.33
1,395.34
1,392.84
1,072.08
990.92
Adjustment
144.94
239.73
189.29
60.01
83.51
32.19
93.87
60.94
91.24
77.55
Changes in Working Capital
418.81
-1,370.45
-264.08
-218.30
-499.84
-219.11
-37.14
-155.03
-125.55
-298.39
Cash after chg. in Working capital
2,932.38
2,552.78
2,591.25
1,661.17
1,438.74
1,044.41
1,452.07
1,298.75
1,037.76
770.07
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-472.65
-640.98
-644.32
-445.23
-484.44
-268.55
-301.70
-260.89
-211.43
-213.32
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-2,707.62
-2,194.92
75.13
-83.47
-685.40
-478.30
-1,139.60
-406.41
-520.84
-305.15
Net Fixed Assets
-481.51
-691.54
-968.33
-1,302.55
-632.52
-255.54
222.19
-288.75
-286.31
-242.98
Net Investments
-5.04
-72.00
971.35
974.24
-56.30
-257.57
-826.05
-77.22
-231.12
-94.07
Others
-2,221.07
-1,431.38
72.11
244.84
3.42
34.81
-535.74
-40.44
-3.41
31.90
Cash from Financing Activity
-797.17
-532.44
-34.89
-1,091.42
-245.94
-314.16
2.38
-631.12
-302.95
-248.50
Net Cash Inflow / Outflow
-1,045.06
-815.56
1,987.17
41.05
22.96
-16.60
13.15
0.33
2.54
3.10
Opening Cash & Equivalents
1,214.76
2,030.32
43.15
2.10
-20.86
-4.26
-17.41
17.62
15.09
11.99
Closing Cash & Equivalent
169.70
1,214.76
2,030.32
43.15
2.10
-20.86
-4.26
17.95
17.62
15.09

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
480.96
441.82
350.15
275.38
262.09
223.20
201.82
161.73
131.67
111.63
ROA
12.37%
22.77%
19.07%
15.11%
15.78%
11.12%
17.21%
22.49%
18.21%
19.92%
ROE
14.89%
28.16%
23.90%
19.30%
21.00%
15.55%
21.98%
28.91%
26.37%
28.31%
ROCE
19.36%
35.06%
32.07%
25.36%
28.50%
21.68%
28.75%
35.57%
33.06%
36.04%
Fixed Asset Turnover
1.30
1.74
1.70
1.77
1.98
1.88
2.06
1.83
1.70
1.66
Receivable days
98.41
83.26
80.66
86.18
80.35
89.33
79.19
77.83
85.12
88.42
Inventory Days
136.05
100.99
104.66
121.62
115.23
124.56
112.34
113.70
121.69
126.52
Payable days
93.12
95.88
106.32
93.73
52.21
60.15
47.14
35.06
33.55
36.16
Cash Conversion Cycle
141.33
88.36
79.00
114.07
143.37
153.75
144.39
156.47
173.26
178.78
Total Debt/Equity
0.00
0.00
0.00
0.00
0.02
0.01
0.01
0.01
0.01
0.01
Interest Cover
1209.48
1842.75
1270.54
255.83
397.38
520.55
416.28
294.75
373.59
336.24

News Update:


  • Divi's Laboratories reports 17% rise in Q3 consolidated net profit
    12th Feb 2024, 12:58 PM

    Consolidated total income of the company increased by 7.08% at Rs 1950 crore for Q3FY24

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.